CHWY vs IDXX vs MKC Stock Comparison

Chewy, Idexx Laboratories and Mccormick Prices as of Nov 13, 2026 Peers: Industry group
CHWY Chewy, Inc.
$22.51 +8.0% 1M -32.8% 1Y
Market cap
$8.79B
P/E
32.1x
Revenue (TTM)
$13.07B
Div. yield
–
Packaged Foods Consumer Staples
1 win
MKC Mccormick & Co Inc
$46.97 +4.8% 1M -28.9% 1Y
Market cap
$12.68B
P/E
8.5x
Revenue (TTM)
$7.69B
Div. yield
0.04%
Packaged Foods Consumer Staples
4 wins

Head to Head

11 decided of 12

Idexx Laboratories leads on 6 of the 12 questions below (Idexx Laboratories 6, Mccormick 4, Chewy 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCHWYIDXXMKCLeader
Larger companyMarket capitalisation $8.79B $55.34B $12.68B IDXX
Cheaper on earningsLower P/E, profitable companies only 32.1x 46.8x 8.5x MKC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 30.0x 44.6x 16.0x MKC
Faster revenue growthRevenue growth, trailing twelve months +5.9% +11.9% +13.2% MKC
More profitableNet margin, trailing twelve months 2.1% 25.4% 19.4% IDXX
Better return on capitalReturn on invested capital — 45.4% 6.0% IDXX
Less leveragedLower net debt / EBITDA 0.0x 0.4x 3.6x CHWY
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.04% –
Better 1-year returnPrice return, last 12 months -32.8% +0.4% -28.9% IDXX
Better 5-year returnAnnualised price return, 5 years -21.8%/yr +2.3%/yr -10.5%/yr IDXX
Less volatileAnnualised volatility, 1 year 47.7% 36.2% 32.3% MKC
Higher overall scoreMean of the five percentile scores vs peers 70/100 76/100 69/100 IDXX

Percentile Scorecard

CHWYIDXXMKC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCHWYIDXXMKC
Valuation 56 #21 of 46 74 #175 of 660 67 #16 of 46
Growth 90 #5 of 42 70 #184 of 619 83 #8 of 42
Profitability 60 #17 of 41 98 #12 of 595 90 #5 of 41
Financial Health 57 #21 of 48 46 #371 of 683 47 #26 of 48
Shareholder Returns 85 #6 of 34 94 #30 of 459 58 #15 of 34
Overall 70 76 69
  • CHWY ranked among 48 companies in Branded Foods
  • IDXX ranked among 695 companies in Pharmaceuticals and Biotechnology
  • MKC ranked among 48 companies in Branded Foods

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCHWYIDXXMKCSPY
1 month +8.0%+33.1%+4.8% -2.0%
3 months +0.4%+27.8%-14.1% -2.8%
6 months +5.8%+33.2%+1.3% +2.0%
Year to date -31.9%+4.1%-31.0% +10.6%
1 year -32.8%+0.4%-28.9% +12.2%
3 years +11.6%+55.0%-29.2% +68.1%
3 years, per year +3.7%+15.7%-10.9% +18.9%
5 years -70.7%+12.1%-42.6% +61.4%
5 years, per year -21.8%+2.3%-10.5% +10.1%
10 years —+545.1%+2.6% +248.5%
10 years, per year —+20.5%+0.3% +13.3%

Risk

MeasureCHWYIDXXMKCSPY
Volatility, 1Y 47.7%36.2%32.3% 13.6%
Downside volatility, 1Y 48.1%32.6%34.5% 13.9%
Beta vs S&P 500, 1Y 0.820.84-0.26 1.00
Return / volatility, 1Y -0.690.01-0.90 0.90
Max drawdown, 5Y -80.3%-50.9%-57.7% -25.4%
From 52-week high -36.4%-8.1%-34.4% -3.2%
52-week high $35.37$766.68$71.65 $779.14
52-week low $17.51$504.70$44.15 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCHWYIDXXMKC
P/E now vs peer median 33.4xmedian 18.9x 47.0xmedian 17.0x 8.5xmedian 18.9x
P/S now vs peer median 0.7xmedian 0.9x 11.9xmedian 8.4x 1.6xmedian 0.9x
EV/EBITDA now vs peer median 19.1xmedian 12.8x 33.7xmedian 14.6x 13.3xmedian 12.8x
P/FCF now vs peer median 15.9xmedian 13.7x 42.6xmedian 19.0x 13.7xmedian 13.7x
P/B now vs peer median 24.4xmedian 1.6x 29.7xmedian 2.0x 1.7xmedian 1.6x
PEG now vs peer median 0.44median 0.70 3.10median 0.43 0.26median 0.70

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCHWYIDXXMKC
Revenue $13.07B $4.66B $7.69B
Gross profit $3.91B $2.92B $3.00B
Operating income $328.20M $1.51B $1.03B
Net income $273.70M $1.18B $1.51B
Free cash flow $568.10M $1.30B $925.90M
R&D – $266.87M –
EPS (diluted) $0.67 $14.96 $5.53
Cash & equivalents $611.00M $197.54M $331.10M
Total debt $591.70M $848.88M $5.02B
Shares (diluted) 410.10M 79.05M 269.40M
Enterprise value $6.08B $54.56B $11.74B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCHWYIDXXMKC
P/E 33.4x 47.0x 8.5x
P/FCF 15.9x 42.6x 13.7x
P/Operating cash flow 12.6x 39.1x 11.1x
P/S 0.7x 11.9x 1.6x
P/B 24.4x 29.7x 1.7x
P/Tangible book 40.9x 31.7x 4.8x
EV/EBITDA 19.1x 33.7x 13.3x
EV/EBIT 27.5x 37.3x 16.8x
EV/Revenue 0.7x 12.0x 2.3x
EV/FCF 15.9x 43.1x 18.7x
EV/Operating cash flow 12.6x 39.6x 15.2x
PEG (3Y EPS CAGR) 0.44 3.10 0.26

Growth

14 metrics
MetricCHWYIDXXMKC
Revenue growth (1Y) 5.9% 11.9% 13.2%
Revenue CAGR (3Y) 6.4% 9.1% 5.2%
Gross profit growth (1Y) 7.6% 13.7% 15.7%
Gross profit CAGR (3Y) 8.5% 10.8% 7.4%
Operating income growth (1Y) 102.0% 15.3% -3.2%
Operating income CAGR (3Y) 139.1% 11.8% 3.5%
Net income growth (1Y) 81.1% 15.1% 93.3%
Net income CAGR (3Y) 73.8% 12.8% 32.7%
EPS growth (1Y) 89.2% 17.4% 91.5%
EPS CAGR (3Y) 76.8% 15.1% 32.2%
Operating cash flow growth (1Y) 17.3% 30.4% 29.8%
Operating cash flow CAGR (3Y) 10.9% 19.6% 2.4%
Free cash flow growth (1Y) 22.7% 35.3% 41.3%
Free cash flow CAGR (3Y) 18.6% 24.2% 5.9%

Profitability

14 metrics
MetricCHWYIDXXMKC
Gross margin 29.9% 62.7% 39.1%
EBITDA margin 3.6% 35.7% 17.0%
Operating margin 2.5% 32.3% 13.4%
Pretax margin 2.7% 31.7% 10.8%
Net margin 2.1% 25.4% 19.4%
FCF margin 4.3% 28.0% 12.0%
Operating cash flow margin 5.5% 30.4% 14.8%
Return on equity 69.0% 67.9% 19.0%
Return on assets 7.8% 33.1% 8.7%
Return on invested capital – 45.4% 6.0%
Return on capital employed 24.9% 65.2% 8.5%
Asset turnover 3.7x 1.3x 0.5x
Cash conversion (OCF / net income) 2.6x 1.2x 0.8x
Stock comp / revenue 2.3% 1.4% 0.6%

Financial Health

11 metrics
MetricCHWYIDXXMKC
Debt / assets 15.8% 22.9% 30.1%
Debt / equity 1.6x 0.5x 0.7x
Net debt / EBITDA 0.0x 0.4x 3.6x
Debt / FCF 1.0x 0.7x 5.4x
Liabilities / assets 90.1% 49.6% 54.4%
Equity / assets 9.9% 50.4% 45.6%
Interest coverage – 43.5x 4.6x
Current ratio 0.8x 1.2x 0.7x
Quick ratio 0.4x 0.7x 0.3x
Cash ratio 0.3x 0.2x 0.1x
Altman Z-score 4.83 23.56 1.80

Shareholder Returns

7 metrics
MetricCHWYIDXXMKC
Dividend yield – – 4.1%
Net buyback yield 5.6% 1.7% -0.1%
Shareholder yield 5.6% 1.7% 4.0%
Payout ratio (earnings) – – 33.6%
Payout ratio (FCF) – – 54.8%
Dividend growth (1Y) – – 6.9%
Dividend CAGR (3Y) – – 7.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCHWYIDXXMKC
Forward P/E 30.0xFY2026 44.6xFY2026 16.0xFY2026
EPS, next fiscal year $0.75FY2026 $15.78FY2026 $2.93FY2026
EPS growth, next FY +44.2%FY2026 +20.6%FY2026 -2.3%FY2026
EPS growth, the year after +49.3% +12.3% +11.9%
Revenue, next fiscal year $12.87BFY2026 $5.03BFY2026 $7.53BFY2026
Revenue growth, next FY +2.1%FY2026 +17.0%FY2026 +10.1%FY2026
Revenue growth, the year after +5.5% +0.4% +12.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCHWYIDXXMKC
Held by institutions 100.0% 93.6% 88.9%
Institutions holding 513 1,292 951
Change in shares held, QoQ -0.4% +4.1% +4.7%
Institutions buying 278 590 479
Institutions selling 156 496 344
Buyers to sellers 1.78 1.19 1.39

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CHWYIDXXMKC
CHWY 1.00 0.33 0.17
IDXX 0.33 1.00 0.24
MKC 0.17 0.24 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CHWY, IDXX and MKC?

Idexx Laboratories (IDXX) is the largest by market capitalisation: Chewy (CHWY) $8.79B, Idexx Laboratories (IDXX) $55.34B, Mccormick (MKC) $12.68B.

Which stock is cheaper, CHWY, IDXX and MKC?

Mccormick (MKC) trades on the lowest price-to-earnings ratio (Chewy (CHWY) 32.1x, Idexx Laboratories (IDXX) 46.8x, Mccormick (MKC) 8.5x). On next year's consensus earnings, Mccormick (MKC) is cheapest (Chewy (CHWY) 30.0x, Idexx Laboratories (IDXX) 44.6x, Mccormick (MKC) 16.0x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Mccormick (MKC) grew revenue fastest over the trailing twelve months: Chewy (CHWY) +5.9%, Idexx Laboratories (IDXX) +11.9%, Mccormick (MKC) +13.2%.

Which company is more profitable?

Idexx Laboratories (IDXX) has the highest net margin (Chewy (CHWY) 2.1%, Idexx Laboratories (IDXX) 25.4%, Mccormick (MKC) 19.4%). On return on invested capital, Idexx Laboratories (IDXX) leads (Idexx Laboratories (IDXX) 45.4%, Mccormick (MKC) 6.0%).

Which stock has performed better?

Over the past year Idexx Laboratories (IDXX) returned the most: Chewy (CHWY) -32.8%, Idexx Laboratories (IDXX) +0.4%, Mccormick (MKC) -28.9%. Over five years, Idexx Laboratories (IDXX) compounded fastest (Chewy (CHWY) -21.8%/yr, Idexx Laboratories (IDXX) +2.3%/yr, Mccormick (MKC) -10.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Chewy (CHWY) 0.00%, Idexx Laboratories (IDXX) 0.00%, Mccormick (MKC) 0.04%. Chewy (CHWY) and Idexx Laboratories (IDXX) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mccormick (MKC) has been the steadiest (Chewy (CHWY) 47.7%, Idexx Laboratories (IDXX) 36.2%, Mccormick (MKC) 32.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CHWY, IDXX and MKC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Idexx Laboratories (IDXX) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.